TechieTricks.com
Verana Health, which unlocks insights from aggregated medical data, raises $150M Verana Health, which unlocks insights from aggregated medical data, raises $150M
Did you miss a session from the Future of Work Summit? Head over to our Future of Work Summit on-demand library to stream. Verana Health, a... Verana Health, which unlocks insights from aggregated medical data, raises $150M


Did you miss a session from the Future of Work Summit? Head over to our Future of Work Summit on-demand library to stream.


Verana Health, a digital health company that leverages big data insights to enhance medical research, has raised $150 million in a series E round of funding.

The San Francisco-based company has formed exclusive data partnerships with a number of notable medical associations, including the American Academy of Ophthalmology, the American Academy of Neurology, and the American Urological Association, to aggregate and analyze anonymized patient data and expedite the development of new drugs. It also claims to work with numerous multinational pharmaceutical companies and “emerging biotechnology and biopharmaceutical companies.”

AI meets health care

Verana Health has two core products — the VeraQ platform, which is pitched as a health data engine that connects disparate, unfiltered healthcare data; and Qdata, which are data sets derived from VeraQ for diseases including ophthalmology, neurology, and urology. The Verana Health platform uses natural language processing (NLP) and machine learning to “preserve the integrity of the original clinical context” of a healthcare provider’s notes and inputs — essentially, making sense of unstructured text data in electronic health records (EHRs).

Founded initially as DigiSight Technologies back in 2008, the company rebranded as Verana Health back in 2018 alongside a $30 million investment led by Alphabet’s venture capital arm GV. With a fresh $150 million in the bank, Verana Health said that it plans to double down on its product development and “expand its data footprint” through building more partnership with the medical and health care fraternity.

For its series E round, Verana Health has attracted a slew of big-name strategic and institutional investors, including lead backers Johnson & Johnson Innovation and Novo Growth, as well as GV, Casdin Capital, Brook Byers, the Merck Global Health Innovation Fund, THVC, and Breyer Capital.

VentureBeat

VentureBeat’s mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact.

Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:

  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more

Become a member



Source link

techietr